FIELD: medicine, pharmaceutics.
SUBSTANCE: there are offered compounds for injections in local lipopexia regions, containing a prolonged selective beta-2-adrenergic receptor agonist selected from salmeterol, formoterol, their salts and their solvates; a compound for decreasing fatty tissue desensitisation to the beta-adrenergic receptor agonist (or a compound for decreasing target tissue desensitisation to the beta-adrenergic receptor agonist - a version); and a liquid carrier, a related method of local treatment of lipopexia regions (versions), a method of decreasing fatty tissue. It is shown that combined use of the ingredients surpasses an effect (e.g., waist size) as compared with intake of only one of them.
EFFECT: development of the method of decreasing fatty tissue.
30 cl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PREPARATIONS FOR TREATING ADIPOSE TISSUE, SKIN TISSUE AND DISORDERS, AND MUSCULAR TISSUE | 2007 |
|
RU2420317C2 |
| METHODS, COMPOSITIONS AND PREPARATIONS FOR TREATING THYROID-ASSOCIATED OPHTHALMOPATHY | 2007 |
|
RU2417100C2 |
| METHOD OF ANIMAL BROKEN WIND TREATMENT AND METHOD OF BROKEN WIND SYMPTOMS RELIEF | 2004 |
|
RU2328279C2 |
| MONTELUKAST SALTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF | 2020 |
|
RU2840778C2 |
| KETOTHIPHEN OPTICALLY ACTIVE ISOMERS AND THEIR THERAPEUTICALLY ACTIVE METABOLITES | 2000 |
|
RU2266115C2 |
| METHODS OF USING THIAZOL DERIVATIVES | 2007 |
|
RU2542502C2 |
| METHOD OF TREATMENT OF PATHOLOGICAL DEVIATIONS AT DIABETES MELLITUS OF TYPE-2 | 1992 |
|
RU2104698C1 |
| PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING CARDIOVASCULAR DISEASES | 2018 |
|
RU2715419C1 |
| INTRAOCULAR SYSTEMS OF SUSTAINED-RELEASE DRUG DELIVERY AND METHOD OF TREATING OPHTHALMIC DISEASES | 2010 |
|
RU2532333C2 |
| TREATMENT OF OBESITY WITH ANTAGONISTS OF MUSCARINIC RECEPTOR M1 | 2007 |
|
RU2455981C2 |
